Phil
PrivateLast Round
Debt
Jul 8, 2025
Total Funding Raised
$151M
Company Overview
Phil is a healthcare technology company that offers a comprehensive platform to enhance the accessibility and affordability of specialty drugs for consumers by connecting patients, prescribers, pharmacies, and manufacturers while streamlining prescription management.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Vertical SaaS, Workflow Automation, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phil Comps
Public and private peers based on sector, stage, and business model.
Phil Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 8, 2025 | ||||
| Series D | Jun 3, 2021 | ||||
| Series B | May 15, 2019 | ||||
| Series A | Aug 16, 2017 |
Phil Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B |
| Uncork Capital | Series A, Series B |
| SV Angel | Series A |
| Tarsadia Capital | Series B |
| Forerunner Ventures | Series A |
| Crosslink Capital | Series B, Series A |
| GreatPoint Ventures | Series B |
Phil Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phil's valuation, stock price, and market status.
